Posted on Sep 27, 2011 By Jennifer Williams
On September 26, 2011 the FDA issued a Drug Safety Communication regarding its safety review of drospirenone-containing oral contraceptives such as Yasmin and Yaz. The FDA bulletin states that while ...
Continue reading "FDA to Convene Panel to Weigh Risks of Yasmin and Yaz" »